Walker E L, Ray C A, Piercey M F
CNS Diseases Research, Pharmacia & Upjohn, Inc., Kalamazoo, MI 49001, USA.
J Neural Transm (Vienna). 1999;106(1):59-74. doi: 10.1007/s007020050141.
Although (+)-UH232 (cis-(+)-5-methoxy-1-methyl-2-(n-dipropylamino)tetralin) and (-)-DS121 (S(-)-3-(3-(cyanophenyl)-N-n-propylpiperidine) are both preferential dopamine autoreceptor antagonists, (-)-DS121 is a more effective behavioral stimulant and dopamine releasing agent. To further compare these two agents, Sokoloff's 2-deoxyglucose autoradiography method was used to study the effects of (+)-UH232 and (-)-DS121 on regional brain energy metabolism. (+)-UH232, 30 mg/kg i.p., depressed metabolism in 37 of 65 brain regions and antagonized the stimulant effects of amphetamine. (-)-DS121, 30 mg/kg i.p., exhibited a strong, nonsignificant trend towards an increase in regional brain energy metabolism by itself and enhanced the stimulant effects of amphetamine. The data demonstrate dramatic differences in the effects of two autoreceptor antagonists on regional brain energy metabolism. It is concluded that, compared to (+)-UH232, (-)-DS121 is a more effective stimulant of brain energy metabolism and autoreceptor antagonist owing to its greater ability to increase DA release.
虽然(+)-UH232(顺式-(+)-5-甲氧基-1-甲基-2-(二丙基氨基)四氢萘)和(-)-DS121(S(-)-3-(3-(氰基苯基)-N-正丙基哌啶)均为选择性多巴胺自身受体拮抗剂,但(-)-DS121是一种更有效的行为兴奋剂和多巴胺释放剂。为了进一步比较这两种药物,采用索科洛夫的2-脱氧葡萄糖放射自显影法研究了(+)-UH232和(-)-DS121对脑区能量代谢的影响。腹腔注射30mg/kg的(+)-UH232可使65个脑区中的37个脑区的代谢降低,并拮抗苯丙胺的兴奋作用。腹腔注射30mg/kg的(-)-DS121本身对脑区能量代谢有强烈但无统计学意义的增加趋势,并增强了苯丙胺的兴奋作用。数据表明,两种自身受体拮抗剂对脑区能量代谢的影响存在显著差异。得出的结论是,与(+)-UH232相比,(-)-DS121由于其更强的增加多巴胺释放的能力,是一种更有效的脑能量代谢刺激剂和自身受体拮抗剂。